STOCK TITAN

CooperCompanies Announces Release Date for First Quarter 2026

Rhea-AI Impact
(Neutral)
Rhea-AI Sentiment
(Neutral)
Tags

CooperCompanies (Nasdaq: COO) will report first quarter 2026 financial results on Thursday, March 5, 2026 at 4:15 PM ET. A conference call will follow at 5:00 PM ET with dial-in 800-715-9871 (conference ID 6529381). A live audio webcast and replay are available at the company investor website.

Loading...
Loading translation...

Positive

  • None.

Negative

  • None.

Key Figures

Earnings release date: March 5, 2026 Release time: 4:15 PM ET Conference call time: 5:00 PM ET +5 more
8 metrics
Earnings release date March 5, 2026 Q1 2026 financial results release scheduled
Release time 4:15 PM ET Q1 2026 results publication time
Conference call time 5:00 PM ET Post-release Q1 2026 conference call
Dial-in number 800-715-9871 Investor conference call access number
Conference ID 6529381 Investor call conference identifier
Current price $80.92 Pre-news close relative to Q1 2026 release notice
52-week high $97.2119 Upper end of 52-week trading range
52-week low $61.775 Lower end of 52-week trading range

Market Reality Check

Price: $82.10 Vol: Volume 1,666,398 vs 20-da...
normal vol
$82.10 Last Close
Volume Volume 1,666,398 vs 20-day average 2,131,384 ahead of earnings date notice. normal
Technical Price $80.92 trading above 200-day MA at $74.74.

Peers on Argus

COO is up about 2% while peers show mixed moves: BAX +5.68%, RMD +4.66%, WST +1....

COO is up about 2% while peers show mixed moves: BAX +5.68%, RMD +4.66%, WST +1.76%, SOLV +0.86%, and HOLX -0.11%, indicating stock-specific factors rather than a unified sector move.

Historical Context

5 past events · Latest: Dec 29 (Neutral)
Pattern 5 events
Date Event Sentiment Move Catalyst
Dec 29 Conference presentation Neutral +0.3% J.P. Morgan Healthcare Conference presentation and webcast availability details.
Dec 23 Board/activist agreement Neutral -1.1% New independent director and cooperation agreement with Browning West.
Dec 04 Strategic review launch Positive +1.7% New Board Chair and formal strategic review with focus on buybacks.
Dec 04 Earnings and guidance Positive +1.7% Q4 and fiscal 2025 results plus fiscal 2026 revenue, EPS and FCF guidance.
Nov 04 Earnings date notice Neutral -0.3% Scheduled Q4 and full-year 2025 results release and conference call details.
Pattern Detected

Recent operational and governance news, plus earnings, have seen largely modest single-day price reactions.

Recent Company History

Over the last few months, CooperCompanies has issued a mix of governance, strategic, and earnings updates. On Dec 4, 2025, it reported Q4 and full-year 2025 results with fiscal 2025 revenue of $4,092.4M and outlined fiscal 2026 guidance, which saw a positive same-day move. That same day it announced a new Chair and a formal strategic review with a focus on a $2B repurchase program. Subsequent items included a release-date notice and a J.P. Morgan conference appearance, both with relatively small price reactions, similar in nature to today’s scheduling announcement.

Market Pulse Summary

This announcement sets the timetable for CooperCompanies’ Q1 2026 financial results on March 5, 2026...
Analysis

This announcement sets the timetable for CooperCompanies’ Q1 2026 financial results on March 5, 2026, with a conference call at 5:00 PM ET. It mirrors the prior pattern of providing dial-in and webcast access for investors. The more material recent context includes Q4 2025 earnings and fiscal 2026 guidance, as well as the ongoing strategic review and share repurchase focus. Investors may watch how upcoming results track against those previously stated targets.

AI-generated analysis. Not financial advice.

SAN RAMON, Calif., Feb. 05, 2026 (GLOBE NEWSWIRE) -- CooperCompanies (Nasdaq: COO), a leading medical device company, announced today it will report first quarter 2026 financial results on Thursday, March 5, 2026, at 4:15 PM ET. Following the release, the Company will host a conference call at 5:00 PM ET to discuss the results and current corporate developments.

The dial-in number for the call is 800-715-9871 and the conference ID is 6529381. A simultaneous audio webcast and subsequent replay can be accessed at http://investor.coopercos.com.

About CooperCompanies
CooperCompanies (Nasdaq: COO) is a leading global medical device company focused on helping people experience life’s beautiful moments through its two business units, CooperVision and CooperSurgical. CooperVision is a trusted leader in the contact lens industry, helping to improve the way people see each day. CooperSurgical is a leading fertility and women’s healthcare company dedicated to putting time on the side of women, babies, and families at the healthcare moments that matter most. Headquartered in San Ramon, CA, CooperCompanies has a workforce of more than 15,000, sells products in over 130 countries, and positively impacts over fifty million lives each year. For more information, please visit www.coopercos.com.

Contact:
Kim Duncan
Vice President, Investor Relations and Risk Management
925-460-3663
ir@cooperco.com


FAQ

When will CooperCompanies (COO) report Q1 2026 results?

CooperCompanies will release its Q1 2026 results on March 5, 2026 at 4:15 PM ET. According to CooperCompanies, a conference call to discuss the results will follow at 5:00 PM ET the same day with an audio webcast available online.

How can investors join the CooperCompanies (COO) Q1 2026 earnings call?

Investors can join by dialing 800-715-9871 and using conference ID 6529381. According to CooperCompanies, a simultaneous audio webcast and replay will be accessible at the company's investor website for remote listeners and for later review.

What time is the CooperCompanies (COO) conference call on March 5, 2026?

The conference call is scheduled for 5:00 PM ET on March 5, 2026, after the results release. According to CooperCompanies, the earnings release is set for 4:15 PM ET, with the call providing management commentary and Q&A for investors and analysts.

Where can I find the CooperCompanies (COO) webcast replay for Q1 2026?

A replay of the audio webcast will be available at http://investor.coopercos.com after the call. According to CooperCompanies, the simultaneous live webcast and subsequent replay will be hosted on the company's investor relations website for on-demand access.

What is the conference ID for CooperCompanies (COO) Q1 2026 call?

The conference ID for the call is 6529381 and the dial-in number is 800-715-9871. According to CooperCompanies, callers should use that ID to join the 5:00 PM ET conference following the 4:15 PM ET results release.
Cooper

NASDAQ:COO

COO Rankings

COO Latest News

COO Latest SEC Filings

COO Stock Data

15.70B
194.70M
0.61%
104.09%
3.31%
Medical Instruments & Supplies
Ophthalmic Goods
Link
United States
SAN RAMON